Lagana bill to require hospitals to provide women with information on breast reconstructive surgery clears committee

Read this article as it originally appeared on

 TRENTON – Legislation sponsored by Senator Joseph Lagana and Senator Vin Gopal, which would require hospitals to provide breast cancer patients with information concerning reconstructive surgery, cleared the Senate Health, Human Services and Senior Citizens Committee.

“Breast cancer is the most commonly diagnosed cancer among women in New Jersey. It is essential that we make sure people have the highest quality care options for treatment and if necessary for reconstruction,” said Senator Lagana (D-Bergen/Passaic). “Our legislation would ensure that treating physicians are not restricted in anyway from helping their patients get individualized care based solely on the clinical and personal needs of that patient.”

The bill, S-3202, requires hospitals to provide breast cancer patients with information concerning reconstructive surgery. The bill also prohibits carriers from preventing the referral of a covered person to an out-of-network surgeon who provides the full scope of breast cancer reconstructive services necessary and appropriate to the patients’ treatment needs.

The information would be provided to the patient in writing and prior to the surgical procedure. The information would include the patient’s right to seek a consultation with a board-certified plastic surgeon of the patient’s choice. This is a description of State and federal laws that require carriers to provide coverage for reconstructive surgery, and the patient’s right to obtain reconstructive surgery from a board-certified plastic surgeon regardless of whether the plastic surgeon is affiliated with the general hospital or health care provider.

The bill was released from committee by a vote of 10-0, and next will head to the full Senate for further consideration.

Showing 1 reaction

Please check your e-mail for a link to activate your account.
  • Katherine Murray
    commented 2019-02-27 19:06:04 -0500
    Will the informed consents include information on ruptured silicone breast implants, cosmetic asymmetries, contractures, and scleroderma, rheumatoid arthritis of hands and lungs downstream? Information that the prostheses are TEMPORARY, not permanent prostheses? That the FDA recommends MRI studies of such breast prostheses every few years in order to detect ruptures and do debridements and replacements earlier before the onset of crippling arthritis (shoulders, hands)?